Dear editor:

According the article “Political will and intersectorality to confront COVID-19 in Cuba”, we need to find more recommendations to fight COVID-19¹. The first sequencing of the SARS-CoV-2 virus began to be published and stored since December 2019. The data generated from genomic studies, such as sequencing, are the basis for studies of molecular epidemiology, population genetics, and studies on diversity genetics².

The use of genomes from sequencing creates new areas to study the details of outbreaks such as molecular epidemiology (MS), is a hybrid of molecular biology within epidemiological studies. Aiming to establish the order of transmission of the pathogen, associate mutations related to its pathogenicity, patterns of transmission of pathogens, reservoirs and source of pathogens ⁽³.

Fundamental support for MS is data that comes from high-throughput sequencing technologies (NGS), in addition to bioinformatics techniques such as genomics and phylogenetics ⁴. Likewise, databases of viral genomes, bioinformatic networks for phylodynamic analyzes, together with an interactive platform for real-time visualization of epidemic outbreaks. These databases are ready to be used to obtain information on various epidemiological aspects related to the virus. The objective of this letter is to present a tool that allows us to visualize and study epidemics in real-time using DNA sequencing of pathogens.

Nexstrain is a clear example of a current bioinformatics tool for MS, this tool allows the visualization of genomes and uses repositories of genomic sequences such as NCBI (www.ncbi.nlm.nih.gov), GISAID (www.gisaid.org) and ViPR (www.viprbrc.org). The platform performs phylodynamic analysis in addition to other tools with phylogenetic inference, temporal dating of ancestral nodes and, probable transmission events ⁵.

Various countries in the world and specifically in the South American region have deposited sequences of the SARS-CoV-2 virus in the mentioned databases and are used by Nexstrain for the elaboration of phylogenetic trees, as well as a map of their possible spread in the world. A descriptive analysis of the molecular epidemiology of SARS-CoV-2 was performed based on the data observed on the Nextrain website. The Nexstrain database was accessed to narrate events regarding the possible route of the virus since its outbreakin Wuhan, China, settling in Europe and its introduction to South America.

The results indicate the following at the South American level: Brazil is the first country to reveal the first genome of the SARS-CoV-2 virus (accession EPI_ISL_412964) on 02/25/2020, indicating an introduction of the virus, from Lombardy, northern Italy. Followed by Argentina (accession EPI_ISL_415700) on 03/01/2020, Chile (accession EPI_ISL_414577) on 03/03/2020, which are associated with groups from Wuhan, China and Taiwan⁵; then Colombia (accession EPI_ISL_418262) on 03/06/2020, Peru (accession EPI_ISL_415787) on 03/10/2020, Uruguay (accession EPI_ISL_426479) on 03/19/2020, finally Ecuador (accession EPI_ISL_422563) revealed the virus genome on 03/30/2020 to the community.

In addition, we review the distribution of deposited genomes worldwide (Table 1). Europe exhibits 45 % of the total (788), followed by North America with 8,1 % (142), being South America (119) and Africa (89) with percentages 6,8 % and 5 % respectively, these being Minor locations represented within the global context. Likewise, we observed a significant representation of clades A2a and A1a for both South America and the various locations globally, indicating some mutations of the sequenced viruses (Figure 1).

We believe that it is important to focus efforts on knowing and identifying a greater number of SARS-CoV-2 samples that circulate in South American countries, especially those countries where there is only one deposited genome, as in the case of Peru. This will allow us to understand the dynamics of transmission of this and the control measures that can be taken to stop the spread of the infection and its possible readmissions. On the other hand, comparing its genomes allows us to determine the degree of existing genetic diversity, that is, how it is mutating, or if it obtained a recombination process, however, there is no mutation associated with its pathogenicity or virulence at the moment.

In conclusion, Nexstrain is a tool that provides support for real-time molecular epidemiology surveillance studies, being of great help through a visualization platform for epidemiologists, virologists, and political decision-makers. Brazil has greater representation being the pioneer, however, South America is poorly represented, highlighting the European clades that were introduced. Further sequencing studies are recommended in patients from South America.